Efficacy and Safety of Gemcabene in Patients With Low HDL-C and Either Normal or Elevated Triglycerides

NCT02585869 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

161

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia
Hypertriglyceridemia

Interventions

DRUG: Gemcabene 150 mg
DRUG: Gemcabene 300 mg
DRUG: Gemcabene 600 mg
DRUG: Gemcabene 900 mg
DRUG: Placebo

Sponsor

NeuroBo Pharmaceuticals Inc.